SGMT 424B3: Secondary offering
Filed with the SEC on · accession 0001193125-26-408210
SGMT filed a 424B3 (prospectus (offering)) with the SEC on Sep 30, 2026. The final terms of an offering of shares or bonds. The stock moved +5.9% by the first close after the filing.
Summary of the filing
Sagimet Biosciences suspended its at-the-market (ATM) equity offering program effective September 30, 2026, with no shares sold to date, while the underlying sales agreement remains in effect.
Key details
How SGMT stock reacted
Close before
$9.33
Sep 29, 2026
First close after
+5.89%
$9.88
5 trading days
-6.11%
$8.76
Since filing
+5.57%
$9.85
✦ Ask GOAX AI about this filing — what it means for SGMT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SGMT?
Click hereFrequently asked questions
What did SGMT file with the SEC on Sep 30, 2026?
SGMT filed a 424B3 (Secondary offering). Sagimet Biosciences suspended its at-the-market (ATM) equity offering program effective September 30, 2026, with no shares sold to date, while the underlying sales agreement remains in effect.
What does a secondary offering mean for SGMT stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B3?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did SGMT stock react to this filing?
SGMT closed at $9.33 before the filing and $9.88 on Sep 30, 2026 (+5.89%). Five trading days later: $8.76 (-6.11%).
Other SGMT SEC filings
- 8-K · SEC filingOct 22, 2026
- SCHEDULE 13G · SEC filingOct 7, 2026
- 8-K · Secondary offeringOct 1, 2026
- 8-K · Fda approvalSep 30, 2026
- SCHEDULE 13G · SEC filingAug 14, 2026
- 8-K · Fda approvalAug 13, 2026
- 10-Q · SEC filingAug 11, 2026
- 8-K · SEC filingAug 11, 2026
- 8-K · SEC filingJul 21, 2026
- 8-K · SEC filingJun 12, 2026
Get alerts when SGMT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days